Object. Cerebral vasospasm after subarachnoid hemorrhage (SAH) continues to be a major source of morbidity in patients despite significant clinical and basic science research. Efforts to prevent vasospasm by removing spasmogens from the subarachnoid spacc have produced mixed results. The authors hypothesize that lumbar cisternal drainage can remove blood from the basal subarachnoid spaces more effectively than an external ventricular drain (EVD). This non randomized, controlled-cohort study was undertaken to evaluate the effectiveness of a lumbar drain in patients with SAH compared with those in whom an EVD or no form of cerebrospinal fluid (CSF) drainage was used to prevent the development of clinical vasospasm and its sequelae.
V elucidated regarding its pathophysiology, it remains an incompletely solved problem. As improved emergency medical services, diagnostic testing, and rapid treatment have decreased the mortality rate from aneurysmal SAH, there has been a concomitant increase in the relative con tribution of vasospasm to the overall outcome. A number of significant achievements have improved our ability to manage vasospasm, but have not eliminated it as a clinical entity.
Abbreviations used in this paper: Cl = confidence interval; CSF = cerebrospinal fluid; CT = computerized tomography; EVD = exter nal ventricular drain; GOS = Glasgow Outcome Scale; ICP = intra cranial pressure; ICU = intensive care unit; MCA = middle cerebral artery; OR = odds ratio; rt-PA = recombinant tissue plasminogen activator; SAH = subarachnoid hemorrhage; TCD = transcranial Doppler.
Foremost among these improvements was the introduc tion of triple-H therapy in the early 1980s.530' 51 Nimodipine, which was introduced for widespread clinical use in 1985, reduced the overall percentage of patients with severe va sospasm from 30 to 20%, but it did not seem to decrease the incidence of vasospasm identified on angiography.2'6'1 -* -49,52,5.? jn iate 1980s, endovascular techniques such as an gioplasty and administration of intraarterial chemical vaso dilators such as papaverine enabled the neurological rescue of many patients, thereby further improving their overall outcomk3' 9'11'12'14'17' 42'*'47'55' 56' 61' Despite all these advances, va sospasm still contributes to poor outcome in approximately 10 to 40% of patients with dense SAH. There is still no effective means to prevent vasospasm, and clinical practice now involves the intensive management of its effects while the disease runs its course. Management of vasospasm cur rently accounts for a substantial proportion of the duration and cost of the hospital stay.
Research has clearly shown that the pathophysiology of vasospasm is directly related to the presence of blood in the subarachnoid space surrounding the cerebral conductance vessels.3*76 Fisher, et al.,is first noted this relationship in 1980, and their grading scheme remains the mostly wide ly applied means of predicting vasospasm risk. 19 Because hemolysis of blood is the primary inciting agent for vaso spasm, it would follow that strategies to facilitate the clear ance of blood from the subarachnoid spaces would decrease cerebral vasospasm. This strategy has been studied by a number of investigators.16-'53' 35,7-4,-44-4S-5a64/;,5J0 7::j4J7 Cister nal administration of thrombolytic/fibrinolytic therapy was first introduced in 1991 and has been thoroughly evaluated, including a well-conducted randomized controlled trial.3236 43, 44, 6 ?-*5,70,71,74,77 a number of Japanese groups have advo cated cisternal irrigation therapy with inflow and outflow catheters placed in the cranial subarachnoid spaces.3537-48-7' This is usually coupled with other modalities such as daily "head-shaking" and fibrinolytic therapy. These therapies have not gained widespread acceptance because of mixed results, the potential for morbidity from placing drains with in the cisternal spaces, and the fear of hemorrhagic compli cations.66 '73 We hypothesized that lumbar CSF drainage may repre sent a simple and effective way to increase the clearance of blood from the subarachnoid spaces and consequently decrease the incidence of clinically significant vasospasm. Draining CSF from the lumbar cistern would be expected to promote circulation of clear, newly formed CSF from the cerebral ventricles through the subarachnoid spaces, espe cially if the arachnoidal membranes and/or lamina terminalis were opened at the time of surgery. Moreover, lumbar drainage would also promote removal of the red cell mass from the intrathecal space, which represents the largest of all subarachnoid cisterns. Conversely, CSF drainage direct ly from the lateral ventricles may contribute to stasis of hemorrhage within the subarachnoid cisterns, so that ven tricular drainage in those patients may actually add to the risk that cerebral vasospasm will develop. We have been using lumbar CSF drainage after SAH for the last 9 years, and now report how this affects the incidence of vasospasm in comparison to a group of patients whose SAH was man aged with conventional or no CSF drainage.
Clinical M aterial and M ethods
This study was made possible by differences in practice preference between two groups of cerebrovascular sur geons at the University of Utah over a 9-year period. One group used EVDs for CSF drainage in the postoperative period, if they believed it was necessary. The other group preferentially used lumbar CSF drainage in patients with high-grade SAHs according to the Fisher scale when this procedure was not contraindicated by safety concerns. Nearly equal numbers of patients with SAH were treated with one of these two management strategies. All other as pects of care, as described later, were similar.
Patient Population
Patients who suffered nontraumatic SAH between Jan uary 1994 and January 2003 were identified from a clinical database maintained in the Department of Neurosurgery at the University of Utah. Clinical records from admission up to the time of discharge were available and were reviewed. The University of Utah's institutional review board autho rized all data collection and analysis.
Patient Demographics and Data
Between January 1994 and January 2003, 266 patients with nontraumatic SAH were treated at the University of Utah Health Sciences Center. From this population, 99 patients were excluded from this study for various reasons. Forty-four patients had only Fisher Grade 1 or 2 hemor rhages; clinically evident vasospasm developed in only one, for an overall incidence of 2.3%. We excluded 27 patients who presented in poor neurological condition and either never significantly improved or died early. An additional 12 patients who were in poor neurological condition after an eurysm treatment were excluded. Finally, 16 patients who presented for treatment 4 or more days after their index hemorrhage were also disqualified. This left 167 patients with high-grade hemorrhages (Fisher Grades 3, 3+4, and 4) who were in satisfactory neurological condition before the onset of vasospasm as the core patient population for this study.
Patient Selection and Clinical Management
All patients were assigned a Hunt and Hess grade' 4 at the time of admission according to neurological parameters only. The presence of serious systemic disease was not used to upgrade the Hunt and Hess score. On arrival, all patients were systemically and neurologically resuscitated and sta bilized, if necessary, with intubation, mannitol, and mod erate hyperventilation therapy. An EVD was placed im mediately if neuroimaging or clinical features indicative of elevated ICP or symptomatic acute hydrocephalus were present. Patients were also classified according to the den sity of their SAH on the initial CT scan by using a modified Fisher grading system. This modification creates a new Grade 3+4 category for patients with both dense subarach noid blood and intraparenchymal/intraventricular hemor rhages of 5 ml or more (diameter > 2 cm). Examples of CT scans obtained in a patient assigned to this Fisher 3+4 cate gory are displayed in Fig. 1 .
We excluded from analysis all patients whose neurologi cal condition was too poor to allow clinical recognition of the signs and symptoms of cerebral vasospasm. This in cluded all patients in Hunt and Hess Grade V who failed to improve substantially with either initial resuscitation or surgical intervention, those who died before clinical vaso spasm developed, patients who sustained a severe neuro logical deficit from aneurysm treatment (coma with Glas gow Coma Scale motor score < 4), and those in whom there was a delay of 4 or more days in presenting to our institution after their index SAH. We did not exclude pa tients who may have sustained a minor sentinel hemorrhage more than 4 days before admission.
With the exception of CSF drainage, all patients received treatment according to a consistent protocol. This included early surgical occlusion of the ruptured aneurysm with clip or coil placement (< 36 hours after admission); prophylac tic hypervolemic therapy with central venous catheters or Swan-Ganz catheters; administration of nimodipine; daily TCD ultrasonography examinations; and rigorous monitor ing and correction of electrolyte, blood gas, and serum anti convulsant drag levels and hydrocephalus. In patients who were treated surgically, the accessible basal cisterns were opened and cleaned of blood by suction and irrigation. All patients underwent cerebral angiography if vasospasm was suspected based on clinical evidence. At the onset of a neu rological change indicative of vasospasm, patients were given a bolus of crystalloid or colloid and their total fluid intake was titrated to a higher central venous pressure, or to the point of maximum cardiac output on the Starling curve if a Swan-Ganz catheter was used. Vasopressor med ications were administered to elevate blood pressure if clin ical improvement was not achieved or sustained with hy pervolemia. At the discretion of the attending surgeon, in consultation with the interventional radiologist, severe or refractory vasospasm was treated with either balloon an gioplasty or repeated intraarterial infusion of papaverine. In three patients (all in the lumbar drainage group), moder ate to severe vasospasm was detected on surveillance TCD studies and angiography in the absence of clinically ap parent neurological change, and prophylactic endovascular therapy was initiated. For the purpose of data analysis, these patients were scored as having vasospasm. Otherwise, pro phylactic angioplasty was not routinely used.
Definition o f Vasospasm and Vasospasm-Related Infarction
Vasospasm was diagnosed using the criteria defined in the tirilizad trials:21--938 1 ) onset of new neurological de ficits such as confusion, disorientation, drowsiness, or focal motor deficit during posthemorrhage Days 4 to 14; 2) neg ative findings on CT scans obtained to rule out other caus es of neurological deterioration such as hemorrhage, cere bral edema, or hydrocephalus; 3) no other identifiable cause of neurological deterioration such as hyponatremia (< 132 mEq/L), hypoxia, drug toxicity, infection, or seizures; and 4) evidence of vasospasm on serial TCD ultrasonography examinations or a cerebral angiogram demonstrating vas cular narrowing affecting a territory concordant with the suspected source of the change in findings on neurological examination. Cerebral infarction caused by vasospasm was diagnosed if either a delayed ischemic deficit became sus tained beyond the risk period of cerebral vasospasm (indi cated by normal results on TCD examination or angiog raphy) or if imaging studies revealed a region of cerebral infarction in a vascular distribution consistent with the pa tient's vasospasm.
Cerebrospinal Fluid Drainage Methods
Any patient who presented with intracranial hyperten sion, which was usually caused by acute symptomatic hy drocephalus, was treated with an EVD in a conventional fashion. Lumbar CSF drainage in these patients was initiat ed only when it was deemed safe, as evidenced by the pres ence of an unobstructed ventricular system and the absence of mass lesions (hemorrhage or cerebral edema) causing midline shift. Lumbar drains were typically placed in pa tients at the time of surgery and were kept closed until post operative Day 1. At the surgeon's discretion, CSF was di verted using the lumbar drain intraoperatively to facilitate brain relaxation. If the postoperative CT scan demonstrated no contraindication, the lumbar drain was opened. In those patients who initially received EVDs for acute or obstruc tive hydrocephalus, we would transition the CSF drain age from the ventricular to the lumbar route as the patient's clinical condition and neuroimaging studies allowed, often overlapping the use of both drains for several days.
Lumbar CSF drainage was continued throughout the va sospasm risk period (drain height 5-10 cm above the exter nal auditory canal); the collection rate was targeted at 5 to 10 ml/hour. Lumbar drainage was stopped once the CSF was no longer visibly hemorrhagic and the risk period for vasospasm had passed. For the purposes of data analysis, we considered only patients in whom lumbar CSF drainage was started by posthemorrhage Day 4 and continued for a minimum of 3 days to have undergone an effective trial of lumbar drainage.
Outcome Measures
There were five primary outcome measures in this study: 1 ) clinically evident vasospasm; 2 ) use of cerebral angio plasty and/or intraarterial papaverine infusion; 3) vaso spasm-related cerebral infarction; 4) disposition of the pa tient at the time of discharge; and 5) GOS26 score at 1-to 3-month follow up. Secondary outcome measures included duration of stay in the ICU, overall acute hospital duration of stay (excluding inpatient rehabilitation), and the need for permanent CSF diversion (shunt placement).
Calculations and Statistical Analysis
Tests of associations between the primary outcome mea- £ Includes patients with multiple aneurysms in whom the source of the hemorrhage could not be reliably determined ( internal carotid artery bifur cation aneurysms, distal anterior cerebral artery aneurysms, and so on).
sures and the method of CSF drainage were performed using chi-square analysis. Statistical significance was set at probability values of less than 0.05. Subgroup-specific analysis was also performed. Potential confounding fac tors were investigated using multivariate logistic regres sion. The ORs and their 95% CIs obtained from the logistic regression models are reported. All statistical analysis was performed using commercially available software (Stata Corp., College Station, TX).
R esu lts
The creation of a Fisher Grade 3+4 category (51 patients) proved useful because these individuals had the highest overall risk of vasospasm. Figure 1 upper illustrates a typ ical example of a Fisher Grade 3+4 hemorrhage, and Fig.  1 lower illustrates, based on our data, the risk of clinical ly evident vasospasm as a function of this modified Fisher scale. Among our patients in Fisher Grade 1 or 2, symptom atic vasospasm developed in only one patient, and that pa tient is believed to have suffered a sentinel hemorrhage 4 days before admission. Regardless of treatment group, 24% of Fisher Grade 3 patients and 59% of Fisher Grade 3+4 pa tients experienced clinically significant vasospasm. Patients who were assigned a Fisher grade of 4 were relatively few (five patients). Of these individuals vasospasm developed in two, both of whom harbored MCA aneurysms with large perisylvian intraparenchymal hemorrhages and suffered va- sospasm in the MCA distribution. We believe that their va sospasm occurred as a result of the surgical evacuation of the hematoma through the sylvian fissure, which placed it in communication with the adjacent subarachnoid space.
The methods used for CSF drainage were as follows: an EVD was used in 68 patients (40.7%) and no form of drainage was used in 18 ( 10 .8%); these groups constitut ed our control cohort of 86 patients. Fifty-eight patients (34.7%) received postoperative lumbar drains and another 23 (13.8%) required EVDs initially but were converted to lumbar drains postoperatively, within 4 days of their hem orrhage. These last two groups composed our lumbar drain cohort of 81 patients. The characteristics of the two cohorts are shown in Table 1 . Using chi-square tests, differences in the composition of the two groups were evaluated. There were no differences in patient age. Hunt and Hess grade, source of hemorrhage, intraoperative rupture, or use of en dovascular coils. Nevertheless, there were statistical dif ferences between the two groups in the Fisher grade (p = 0.001), and whether an EVD was placed on admission (p = 0.024). The control group included more Fisher Grade 3+4 patients (39% compared with 21%) and had more patients who required an EVD on admission (51 % compared with 33%) compared with the lumbar drain group. All of the nonaneurysmal hemorrhages (19 lesions) included in this study represented patients with densely packed, pan-cister nal hematomas, not the classic perimesencephalic hemor rhage in a patient at low risk for vasospasm. Surgery was performed in 80% of patients in the lumbar drain group compared with 88% in the control group, and only three pa tients in each group were treated with coil placement.
Primary and Secondary Outcomes
As illustrated in Fig. 2 , the effect of lumbar CSF drain age on mobilization of blood from the subarachnoid space was dramatic. Typically, CSF from the lumbar cistern was densely hemorrhagic for the initial days of CSF drainage and then progressively cleared. By contrast, CSF drained 19 (24) 28 (36) 0.145 * Scores w'ere assigned at 1-to 3-month follow-up review's. The GOS score could not be accurately assessed for two patients in the LD group and eight in the control group. Abbreviation: LOS = length of stay.
from the ventricle was often considerably less hemorrhag ic, indicating limited circulation within the subarachnoid space before withdrawal. Table 2 shows the effects of using lumbar CSF drainage on our various primary outcome measures. For the entire cohort of patients, lumbar CSF drainage significantly re duced the incidence of clinical vasospasm from 51 to 17%, the need for endovascular vasospasm treatment from 45 to 17%, and the risk of cerebral infarction from 27 to 7%. Those patients who did not receive a lumbar drain had a 2.9-, 2.6-, and 3.7-fold greater risk of experiencing clinical vasospasm, requiring endovascular procedures, and suf fering a stroke, respectively, than those in whom a lumbar drain was placed. Another means of assessing the effective ness of a lumbar drain is to calculate the number of patients who needed to be treated to prevent adverse outcomes. The number of patients who need to be treated with a lumbar drain to prevent one case of vasospasm and one of stroke are three and five, respectively. Four patients need to be treated with a lumbar drain before one patient is spared an endovascular procedure for vasospasm.
Lumbar CSF drainage also had a positive influence on patient disposition and functional outcome. As seen in Table 2 , the proportion of patients in the lumbar drain group who were discharged directly home was more than twice that of the control group, with corresponding decreases in death, discharge to convalescent facilities, and inpatient rehabilitation. Similarly, twice as many patients in the lum bar drain group had a 1-to 3-month GOS score of 5 com pared with the control group. Patients in the control group spent a mean of 16 days in the ICU, compared with 13 days for the lumbar drain group (t-test, p = 0.0077). Likewise, the mean hospital stay for the control group was longer than that of the lumbar drain group (21 compared with 17 days, t-test, p = 0.0014). O f the possible 162 patients, excluding the five who died before we could determine whether they needed a shunt, 24% in the lumbar drain group and 34% in the control group required a shunt. This difference did not reach statistical significance, however (p = 0.145).
Logistic Regression Analysis
Because there were imbalances in Fisher grade (3 com pared with 3+4) and in the need for EVD on admission (Ta ble 1 ), we analyzed for these effects in two different ways. First, we performed a logistic regression analysis to identi fy factors that predicted the three main binaiy outcomes: clinically evident vasospasm, endovascular treatment, and stroke. Second, we performed a subgroup analysis to look at the effect of lumbar drains within each of these separate demographic variables. For the logistic regression models, the following factors were tested: the presence of a lum bar drain, patient's age, intraoperative rupture of the lesion, EVD on admission, Fisher grade, Hunt and Hess grade, and source of hemorrhage. Table 3 shows the crude ORs for the outcomes and the adjusted ORs from the logistic regression models and their respective 95% CIs. The protective bene fit of a lumbar drain with respect to the outcomes did not change significantly when controlled for the factors list ed earlier. Covariates were considered useful in predicting the outcome of interest if their probability value was less than 0.15. The factors that were found to predict the devel opment of clinical vasospasm were as follows: the pres ence of a lumbar drain (p < 0. 
Subgroup Analysis
We performed a subgroup analysis to look at the effect of lumbar CSF drainage within individual Fisher grades and among patients who did and did not require preoperative EVDs (Table 4 ). Within Fisher Grade 3 patients only, lum bar CSF drainage significantly reduced the relative risk of clinical vasospasm, endovascular procedures, and cerebral infarction, by 6 8 , 57, and 78%, respectively. In the Fisher Grade 3+4 group only, the relative risk reduction of clinical vasospasm and the need for endovascular intervention was 49% for both. Although the relative risk of cerebral infarc tion was decreased by 47%, this did not reach statistical sig nificance. Similar results were found in the analysis of patients who did and did not require an EVD on admission.
In the former, the relative risk reduction for clinical vaso spasm and endovascular' procedures was 70 and 67%, re spectively. Again, although there was a dramatic decrease in the risk of cerebral infarction with a lumbar-drain (66%), this was not statistically significant (p = 0.05). For patients who did not require an EVD, the relative risk reductions for clinical vasospasm, need for endovascular-intervention, and stroke were 58, 48, and 75%, respectively. Here, the reduc tion in endovascular-procedures did not reach statistical sig nificance.
Drain Complications
Occasional complications occurred with both lumbar drains and EVDs, as follows. On removal of their EVDs, two patients suffered an intracerebral hemorrhage that re quired surgical evacuation. There were a number of other patients with small, asymptomatic hemorrhages that did not require treatment. In the lumbar drain group, no patient de veloped subdural hematomas or hygromas. In two patients in both the lumbar-drain and EVD groups, culture-positive meningitis/ventriculitis developed while the drains were in place. In all cases, these infections resolved after treatment with antibiotic drugs and removal or changing of the drain, with no permanent sequelae. In both groups, there were two patients in whom the catheters broke and surgery was re quired to retrieve the broken end. Thr ee patients in the lum bar-CSF drain group were observed to show signs of tran 47 19 (40) 0 (24) 0.010 18 75 sient clinical or neurological worsening when CSF drainage was initiated. This consisted of a decreased level of respon siveness in all cases and bradycardia in two, but these signs cleared rapidly after clamping of the drain. We were able to recommence lumbar-CSF drainage successfully within 24 to 36 hours, initially at a slow rate and then progressing to our target rate, without further difficulty. None of these three patients suffered vasospasm.
D isc u ssio n

Impact o f Vasospasm After SAH
The impact of cerebral vasospasm on outcome after SAH has steadily declined over the past two decades, although it is still an important clinical issue. Data from the Interna tional Cooperative Study on the Timing of Aneurysm Sur gery performed in the early 1980s showed that clinical ly significant vasospasm permanently affected 13.5% of all patients and accounted for 33% of deaths and disabilities. *1 With advances in the surveillance and management of vasospasm, more recent studies indicate that 5 to 11% of patients continue to suffer permanent disability as a result of vasospasm.15' 59'66 '67 The current standard of care consists of triple-H therapy, calcium-channel antagonists, and the use of endovascular-reperfusion techniques. Muizelaar, et al.,46 have suggested the use of preemptive cerebral angio plasty in high-risk patients to halt the onset of vasoconstric tion; however, it is not yet clear-if the risk/benefit ratio of such an approach is justified. With the exception of preemp tive angioplasty, none of these current therapies prevents the occurrence of vasospasm, but they do lessen its clinical impact.
Benefits o f Lumbar Drainage
The results of this controlled-cohort study show a marked benefit from lumbar CSF drainage in the following parameters: clinically symptomatic vasospasm, need for en dovascular intervention, occurrence of vasospasm-induced cerebral infarction, disposition at discharge, number of days in the ICU and total acute hospital care days, and GOS score measured at 1 to 3 months after discharge. The only outcome that did not show a statistical improvement with lumbar drainage was the need for a CSF shunt. Despite dif ferences between the lumbar drain and control groups with respect to Fisher grade and placement of an EVD on admis sion, the degree of protection provided by the lumbar drain was consistent throughout multivariate logistic regression analysis and separate subgroup analyses. The absence of a lumbar drain was consistently the strongest predictive fac tor for clinically evident vasospasm, need for endovascular procedures, and vasospasm-induced cerebral infarction.
Although we have performed our analysis in a subset of all patients with SAH presenting to the University of Utah Health Sciences Center, the effect of these exclusions was to eliminate patients at low risk for vasospasm (Fisher Grade 1 or 2), and those whose neurological condition after their hemorrhage or treatment was too poor to be impact ed by any subsequent vasospasm. The only other group we excluded from analysis was a small number of patients who were admitted with a delay of 4 or more days after their SAH. Although this group was too small to alter our results, we believe that this exclusion was justified on the prem ise that early initiation of therapy would be necessary to achieve protection. All other patients were included in this study. Even with these exclusions, demographic analysis showed that our patient population represented a typical cross-section of patients with SAH. All patients were treat ed by specialists in cerebrovascular surgery and with a con sistent postoperative vasospasm protocol, so that the only identifiable treatment differences were related to the use of lumbar CSF drains or EVDs.
Causes of and Treatments for Vasospasm
Research on the pathophysiology of cerebral vasospasm has related the occurrence of arterial narrowing to biochem ical processes that are initiated as blood undergoes lysis within the subarachnoid space. Factors that have been im plicated include oxyhemoglobin, iron, intracellular adhe sion molecule-1 , endothelins, nitrous oxide, reduced form of nicotinamide-adenine dinucleotide phosphate oxidase, vascular endothelial growth factor, and arachidonic acid derivatives.10' 7' 8343'^41-45-54-75-7' 3 Several clinical strategies for reducing cerebral vasospasm have been developed based on these mechanisms.4-1' 3-2' 57-' 38 Fibrinolytic agents, such as uro kinase or rt-PA, have been extensively studied.1' 33' 3-43-44-' 3^'35-70,71,74,77 -phg j-esuits from these studies indicate that there may be at best a slightly decreased risk of vasospasm in the treated groups.
A well-designed multicenter randomized trial performed in 1995 did not show a difference in angiographically con firmed or symptomatic vasospasm between patients treated with a single intraoperative injection of rt-PA and their con trol group.1' 3 Nevertheless, when only patients with a thick subarachnoid clot were analyzed, there was a 56% relative risk reduction of severe vasospasm in the group treated with rt-PA. In contrast to this study, Kodama and colleagues353' 3 have provided evidence of a significant benefit with fibri nolytic therapy in an uncontrolled, nonrandomized cohort study. They administered urokinase and ascorbic acid into irrigation tubes placed in the sylvian fissure (inlet) and prepontine or chiasmal cisterns (outlet) at the time of aneurysm clip occlusion in 222 consecutive patients with Fisher Grade 3 SAHs. Ascorbic acid was added because it has been shown to degrade oxyhemoglobin into verdohemelike products, which are thought to have no prospasmogenic properties.37 Clinical vasospasm occurred in only six patients (2.7%), two of whom suffered permanent sequelae (0.9%). Despite these promising results, such treatment has not yet become widely incorporated into current clini cal care.
Rationale for CSF Drainage
A number of Japanese surgeons have been using CSF drainage methods, including lumbar drains, since the early 1980s, with mixed results.3233-' 31 The results of our study are consistent with the concept of a CSF-soluble spasmogenic agent(s). The rationale underlying our use of lumbar CSF drainage is that it promotes CSF circulation from the ven tricles through the subarachnoid spaces, and that it also evacuates the large reservoir of bloody CSF from the spinal cistern. Conversely, CSF drainage from the ventricles may actually promote stasis within the subarachnoid space. It is our impression that patients who underwent lumbar CSF drainage had more rapid clearance of neuroimaging-depict ed blood from the subarachnoid spaces than did control patients, although this aspect was not specifically measured in this study. Moreover, of the few patients with lumbar CSF drainage in whom vasospasm developed, many had loculated pockets of hemorrhage within the subarachnoid cisterns or a delay in clot lysis and clearance. Based on these findings, we believe that it may be possible to enhance the overall effectiveness of lumbar CSF drainage on vaso spasm even further if the device was either combined with an irrigation catheter in the ventricles or basal cisterns, or if its use was combined with infusion of thrombolytic agents. We do not believe that the protective effect of the lumbar drain is gained simply through a decrease in the ICP, thus promoting cerebral perfusion. In both our lumbar drain and EVD groups, CSF diversion yielded similar values of ICP and for similar durations, and both TCD data and angio graphic results showed decreased vascular narrowing in the lumbar drain group. Another aspect of this therapy that needs further investigation is whether opening the various arachnoidal compartments in the basal cisterns or opening the lamina terminalis facilitates CSF circulation and clear ance of subarachnoid blood.
Complications of Lumbar Drainage
Lumbar drains are currently used in a variety of surgical scenarios, and are already commonly used in aneurysm surgery for facilitation of brain relaxation intraoperatively. 7 The published experience with lumbar drains documents that they can be associated with a variety of complications.1-58-' 3' ' 39 Catheter breakage and infection are inherent risks of both EVDs and lumbar drains, and this occurred equally in both groups. Lumbar drains, unlike EVDs, can not be a direct cause of intracranial hemorrhages, but can cause them indirectly, especially if CSF drainage is overly aggressive. Tension pneumocephalus is a complication of lumbar CSF drainage that has been reported after transsphe noidal surgery, and could be a risk related to aneurysm surgery if the frontal or ethmoidal sinuses are violated and not adequately repaired.'' Both spinal nerve root injury and post-dural puncture headache are reported complications of spinal CSF drainage,'0 but were not encountered in our study. Cerebral herniation leading to death or neurologi cal injury is the most feared complication of lumbar CSF drainage, especially in postoperative patients or those with intracranial diseases causing mass effect. We avoided this complication by using a strict protocol requiring a satisfac tory postoperative CT scan before CSF drainage was com menced, and by avoiding the use of drains in patients with mass lesions that caused any significant cerebral midline shift.
We encountered several patients who transiently became less responsive at the start of lumbar CSF drainage with im mediate resolution of symptoms after clamping of the drain. Two of these patients had posterior fossa SAHs from pos terior inferior cerebellar artery aneurysms and one had a partially evacuated large intracerebral hematoma from an MCA aneurysm. In all of these individuals, we were able to resume lumbar CSF drainage safely within 24 hours. None of these patients suffered vasospasm despite having very substantial SAH. In all respects, safe use of postoperative lumbar CSF drainage in patients with aneurysms requires strict attention to detail, close surveillance, and an experi enced team of neurologically trained critical care nurses.
Limitations of the Study
There are several limitations in terms of methodology and outcomes in this cohort study. Selection bias is always a potential problem in a nonrandomized study, although case assignment did have a randomizing effect. Thus, pa tients were assigned randomly by the call schedule to attending physicians who either never used lumbar CSF drainage (control group) or to physicians who always used it as long as it was not contraindicated (treatment group). The only selection bias we could identify was a tendency to use lumbar drains less frequently in the group of patients harboring both dense cisternal subarachnoid blood and intracerebral hemorrhages (our Fisher Grade 3+4 group). As can be seen in Table 1 , there were more patients in the control group with a Fisher Grade 3+4 hemorrhage com pared with the intervention (lumbar drain) group. This is important because this group has the highest risk of suffer ing vasospasm. Likewise, lumbar CSF drainage was not used at all in our few patients with exclusively intracerebral and/or intraventricular hemorrhage (Fisher Grade 4) . This imbalance occurred because of safety concerns about the use of lumbar CSF drainage in patients with intracerebral hematomas. Lumbar drains were used in some of these pa tients (the ones whose hematomas had been sufficiently evacuated or did not cause major mass effect), and in these individuals the severity of cerebral vasospasm was signifi cantly reduced (Table 2) . Nevertheless, the difference in the Fisher grade composition of the two groups did not prove to be a confounding factor based on our logistic regression modeling. Another limitation in our study was the fact that the data acquisition covered a period of 9 years; therefore, the data are limited by the quantity and quality of the infor mation obtained from the medical records.
In this study we have not presented any data as to wheth er lumbar CSF drainage prevents neuroimaging-conllrmed cerebral vasospasm. This question will be specifically ana lyzed in a separate study; however, our overwhelming impression so far is that lumbar CSF drainage actually pre vents arterial narrowing. The majority of patients with lum bar CSF drainage were noted to display only mild elevation of blood flow velocities on TCD studies, and surveillance angiography between SAH Days 7 and 9 revealed only lim ited vasospasm on neuroimages. Finally, in this study we primarily evaluated the acute management and sequelae of vasospasm and did not assess any long-term outcome be yond the 1-to 3-month GOS scores. We would expect that early favorable outcomes would be reflected in long-term favorable outcomes as well, but this will need to be con firmed in future studies.
C o n clu sio n s
This controlled, nonrandomized cohort study represents our extensive experience with lumbar CSF drainage over the last 9 years. With this technique, we have shown a marked reduction in the risk of suffering clinically symp tomatic vasospasm, vasospasm-induced stroke, and in the need for endovascular procedures for neurological rescue. Number of days in the ICU and overall hospital stay were reduced, as was the need for rehabilitation or convalescent care. The risk of chronic hydrocephalus, however, was not significantly changed with use of a lumbar drain, although there was a favorable trend. Lumbar drains are believed to decrease cerebral vasospasm by promoting circulation of CSF and clearance of blood from the subarachnoid spaces. The complication rate with lumbar drains was no greater than that associated with EVDs, but appropriate precautions must be observed when using the former. On the basis of our study, a randomized prospective trial of this therapy is warranted and is currently under way. The present report was primarily a surgical aneurysm series, and this approach should also be investigated to see if it would decrease cere bral vasospasm in endovascularly treated patients as well. 
